Sentinel lymph node biopsy in early breast cancer: The first 100 cases performed in a teaching institute

Israel Medical Association Journal

Volumn 5, Issue 8, 2003, Pages 556-559

  Mahajna, Ahmad ^a,b   Hershko, Dan D ^a,b   Israelit, Shlomi ^a,b   Abu Salih, Adel ^a,b   Keidar, Zohar ^a,b   Krausz, Michael M ^a,b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Axillary lymph node dissection; Blue dye; Lumpectomy; Lymphoscintigraphy

Indexed keywords

BIOPSY; PATIENT TREATMENT; SURGERY;

BREAST CANCERS;

TUMORS;

DYE; TRACER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS; SURGEON;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AXILLA; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HOSPITALS, TEACHING; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0042066340     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Breast. In: Fleming ID, Cooper JS, Henson De, eds. AJCC Cancer Staging Manual. 5th edn. Philadelphia: Lippincott-Raven, 1977:171-80.
2. Bonadonna G, Valagussa P, Moliterni A, Zambetti M, Brambilla C. Adjuvant cyclophosphamide, methotrexate and fluorouracil in nodepositive breast cancer: The result of 20 years of follow-up. N Engl J Med 1995;332:901-6.
3. Bonadonna G. Karnofsky Memorial Lecture: Conceptual and practical advances in the management of breast cancer. J Clin Oncol 1989;7:1380-97.
4. Overmoyer BA. Chemotherapy in the management of breast cancer. Cleveland Clin J Med 1995;62:36-50
5. Bouedec LG, Pomel C, Chamussy E, Feillel V, De Latour M, Dauplat J. Axillary lymph node dissection in clinically occult breast cancer. Bull Cancer 1996;83:581-8.
6. Petrek JA, Blackwood MM. Axillary dissection: Current practice and technique. Curr Prob Surg 1995;32:257-323.
7. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
8. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage 1-2 carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1575-82.
9. Cabanas RM. An approach to penile carcinoma. Cancer 1977;39:456-60.
10. Morton DL, Wen DR, Wong JH. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
11. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
12. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
13. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
14. Raymond WA, Leong AS. Immunoperoxidase staining in the detection of lymph node metastases in stage 1 breast cancer. Pathology 1989;21:11-15.
15. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: A multicenter validation study. N Engl J Med 1998;339:941-6.
16. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
17. Zavagno G, Busolin R, Bozza F, et al. Sentinel node biopsy in breast cancer. Breast 2000;9:139-43.
18. Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248-54.
19. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
20. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999;189:539-45.
21. Cody HS. Clinical aspects of sentinel lymph node biopsy. Breast Cancer Res 2001;3:104-8.
22. Veronesi U, Paganelli G, Viale G, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864
23. McMasters KM, Wong SL, Martin RC 2d, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: Results of a multi-institutional study. Ann Surg 2001;233:676-87.
24. Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.